Skip to main content

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Zhangmen Education Inc. (ZME)

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zhangmen Education Inc.(“Zhangmen” or the “Company”) (NYSE: ZME) American Depositary Shares (“ADSs or shares”) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s June 2021 initial public offering (“IPO”).

If you suffered a loss on your Zhangmen investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/zhangmen-education-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

In June 2021, Zhangmen, an education company focused on providing personalized online courses to K-12 students in China, conducted its IPO, selling 4,166,450 ADSs at a price of $11.50 per ADS.

Then, on July 23, 2021 China revealed an extensive overhaul of its education sector, prohibiting companies that teach the school curriculum from making profits, raising capital or going public. This effectively ended China’s $120 billion private tutoring industry.

On July 26, 2021, Zhangmen issued a release stating that these new guidelines were likely “to have material impacts on our existing business operations, financial condition and corporate structure.”

Then, on November 19, 2021, Zhangmen announced that its independent auditor had resigned.

On November 19, 2021, the Company’s share price closed at $1.47 per ADS, an 80% decline from the IPO price.

The complaint filed in this class action alleges that the Registration Statement failed to disclose that: (a) the People’s Republic of China (“PRC”) authorities were in the process of implementing sweeping new regulatory reforms on the private education industry in China including, among others, prohibitions on: (i) profit-making by private education companies, (ii) engaging in core-curriculum tutoring on weekends and vacations, and (iii) capital-raising by companies like Zhangmen; (b) the known risks, events, and uncertainties noted in the Registration Statement were reasonably likely to have a material adverse effect on Zhangmen’s business; and (c) based on the foregoing, the statements in the Registration Statement concerning Zhangmen’s historical financial performance, market demand, and industry trends were materially incomplete, inaccurate, and misleading.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Zhangmen ADSs pursuant and/or traceable to the IPO, you may move the Court no later than January 18, 2022 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.